PhotonPharma Inc. Appoints Vaccine Innovation Leader William Warren, Ph.D. to Board of Directors
PR Newswire —
FORT COLLINS, Colo., Jan. 22, 2026 /PRNewswire/ -- PhotonPharma Inc., a leader in autologous cancer immunotherapies developing Innocell™ for stage III/IV ovarian cancer, today announced the appointment of William Warren, Ph.D., to its Board of Directors, effective immediately. Dr. Warren...